請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47325
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 謝學真 | |
dc.contributor.author | Yin-An Chen | en |
dc.contributor.author | 陳瀅安 | zh_TW |
dc.date.accessioned | 2021-06-15T05:55:05Z | - |
dc.date.available | 2020-12-31 | |
dc.date.copyright | 2010-08-19 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-08-17 | |
dc.identifier.citation | 1. Langer, R. and J.P. Vacanti, Tissue engineering. Science, 1993. 260(5110): 920-926.
2. Weissman, I.L., D.J. Anderson, and F. Gage, Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annual Review Cell Developmental Biology, 2001. 17: 387-403. 3. Watt, F.M. and B.L. Hogan, Out of Eden: stem cells and their niches. Science, 2000. 287(5457): 1427-1430. 4. Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, and J.M. Jones, Embryonic stem cell lines derived from human blastocysts. Science, 1998. 282(5391): 1145-1147. 5. Shirakura, M., K. Tanimoto, H. Eguchi, M. Miyauchi, H. Nakamura, K. Hiyama, K. Tanimoto, E. Tanaka, T. Takata, and K. Tanne, Activation of the hypoxia-inducible factor-1 in overloaded temporomandibular joint, and induction of osteoclastogenesis. Biochemical and Biophysical Research Communications, 2010. 393(4): 800-805. 6. Gimble, J.M. and F. Guilak, Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy, 2003. 5(5): 362-369. 7. Zech, N.H., Adult Stem Cell Manipulation and Possible Clinical Perspectives. Journal of Reproductive Medicine and Endocrinology, 2004. 1(2): 91-99. 8. Bruder, S.P., N. Jaiswal, and S.E. Haynesworth, Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. Journal of Cellular Biochemistry, 1997. 64(2): 278-294. 9. Caplan, A.I., Mesenchymal stem cells. Journal of Orthopaedic Research., 1991. 9: 641-650. 10. Mets, T. and G. Verdonk, In vitro aging of human bone marrow derived stromal cells. Mechanisms of Ageing and Development, 1981. 16(1): 81-89. 11. Zohar, R., J. Sodek, and C.A. McCulloch, Characterization of stromal progenitor cells enriched by flow cytometry. Blood, 1997. 90(9): 3471-3481. 12. Wang, J.S., D. Shum-Tim, J. Galipeau, E. Chedrawy, N. Eliopoulos, and R.C. Chiu, Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. Journal of Thoracic and Cardiovascular Surgery, 2000. 120(5): 999-1005. 13. Orlic, D., J. Kajstura, S. Chimenti, D.M. Bodine, A. Leri, and P. Anversa, Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant, 2003. 7 (3): 86-88. 14. Orlic, D., J. Kajstura, S. Chimenti, I. Jakoniuk, S.M. Anderson, B. Li, J. Pickel, R. McKay, B. Nadal-Ginard, D.M. Bodine, A. Leri, and P. Anversa, Bone marrow cells regenerate infarcted myocardium. Nature, 2001. 410(6829): 701-705. 15. Black, I.B. and D. Woodbury, Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells, Molecules, Diseases., 2001. 27(3): 632-636. 16. Woodbury, D., E.J. Schwarz, D.J. Prockop, and I.B. Black, Adult rat and human bone marrow stromal cells differentiate into neurons. Journal of Neuroscience Research, 2000. 61(4): 364-370. 17. Sanchez-Ramos, J., S. Song, F. Cardozo-Pelaez, C. Hazzi, T. Stedeford, A. Willing, T.B. Freeman, S. Saporta, W. Janssen, N. Patel, D.R. Cooper, and P.R. Sanberg, Adult bone marrow stromal cells differentiate into neural cells in vitro. Experimental Neurology, 2000. 164(2): 247-256. 18. Theise, N.D., M. Nimmakayalu, R. Gardner, P.B. Illei, G. Morgan, L. Teperman, O. Henegariu, and D.S. Krause, Liver from bone marrow in humans. Hepatology, 2000. 32(1): 11-16. 19. Alison, M.R., R. Poulsom, R. Jeffery, A.P. Dhillon, A. Quaglia, J. Jacob, M. Novelli, G. Prentice, J. Williamson, and N.A. Wright, Hepatocytes from non-hepatic adult stem cells. Nature, 2000. 406(6793): 257. 20. Petersen, B.E., W.C. Bowen, K.D. Patrene, W.M. Mars, A.K. Sullivan, N. Murase, S.S. Boggs, J.S. Greenberger, and J.P. Goff, Bone Marrow as a Potential Source of Hepatic Oval Cells. Science, 1999. 284(5417): 1168-1170. 21. Luo, K., J. Yin, Z. Song, L. Cui, B. Cao, and X. Chen, Biodegradable Interpolyelectrolyte Complexes Based on Methoxy Poly(ethylene glycol)-b-poly(α,l-glutamic acid) and Chitosan. Biomacromolecules, 2008. 9(10): 2653-2661. 22. Minguell, J.J., A. Erices, and P. Conget, Mesenchymal Stem Cells. Experimental Biology and Medicine., 2001. 226(6): 507-520. 23. Hung, S.C., D.M. Yang, C.F. Chang, R.J. Lin, J.S. Wang, L. Low-Tone Ho, and W.K. Yang, Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes. International Journal of Cancer, 2004. 110(3): 313-319. 24. Essentials of stem cell biology. 2009. 25. Shirakura, M., K. Tanimoto, H. Eguchi, M. Miyauchi, H. Nakamura, K. Hiyama, E. Tanaka, T. Takata, and K. Tanne, Activation of the hypoxia-inducible factor-1 in overloaded temporomandibular joint, and induction of osteoclastogenesis. Biochemical Biophysics Research Communications, 2010. 393(4): 800-805. 26. Pittenger, M.F., A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak, Multilineage potential of adult human mesenchymal stem cells. Science, 1999. 284(5411): 143-147. 27. Mareschi, K., E. Biasin, W. Piacibello, M. Aglietta, E. Madon, and F. Fagioli, Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica, 2001. 86(10): 1099-1100. 28. Lin, H.-R., K.-S. Chen, S.-C. Chen, C.-H. Lee, S.-H. Chiou, T.-L. Chang, and T.-H. Wu, Attachment of stem cells on porous chitosan scaffold crosslinked by Na5P3O10. Materials Science and Engineering: C, 2007. 27(2): 280-284. 29. Anfosso, F., N. Bardin, E. Vivier, F. Sabatier, J. Sampol, and F. Dignat-George, Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. Journal of Biological Chemistry, 2001. 276(2): 1564-1569. 30. Wozney, J.M., V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, R.W. Kriz, R.M. Hewick, and E.A. Wang, Novel regulators of bone formation: molecular clones and activities. Science, 1988. 242(4885): 1528-1534. 31. Bruder, S.P., D.J. Fink, and A.I. Caplan, Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy. Journal of Cellular Biochemistry, 1994. 56(3): 283-294. 32. Jaiswal, N., S.E. Haynesworth, A.I. Caplan, and S.P. Bruder, Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Journal of Cellular Biochemistry, 1997. 64(2): 295-312. 33. Bruder, S.P., N. Jaiswal, and S.E. Haynesworth, Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. Journal of Cell Biochemistry, 1997. 64(2): 278-294. 34. Graves, S.E., M.J.O. Francis, R. Gundle, and J.N. Beresoford, Primary culture of human trabecular bone: Effects of L-ascorbate-2-phosphate. . Bone, 1994a. 15: 132-133. 35. Graves, S.E., M.J.O. Francis, and J.N. Beresoford, Ascorbate increases collagen synthesis and promote differentiation in human bone derived cell cultures. Bone, 1994b. 15: 132-133. 36. Vukicevic, S., F.P. Luyten, and A.H. Reddi, Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proceedings of the National Academy of Sciences of the United States of America, 1989. 86(22): 8793-8797. 37. Rickard, D.J., T.A. Sullivan, B.J. Shenker, P.S. Leboy, and I. Kazhdan, Induction of Rapid Osteoblast Differentiation in Rat Bone Marrow Stromal Cell Cultures by Dexamethasone and BMP-2. Developmental Biology, 1994. 161(1): 218-228. 38. Jørgensen, N.R., Z. Henriksen, O.H. Sørensen, and R. Civitelli, Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids, 2004. 69(4): 219-226. 39. Kamalia, N., C.A. McCulloch, H.C. Tenebaum, and H. Limeback, Dexamethasone recruitment of self-renewing osteoprogenitor cells in chick bone marrow stromal cell cultures. Blood, 1992. 79(2): 320-326. 40. Jorgensen, N.R., Z. Henriksen, O.H. Sorensen, and R. Civitelli, Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids, 2004. 69(4): 219-226. 41. Yeh, L.C.C., A.D. Tsai, and J.C. Lee, Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. Journal of Cellular Biochemistry, 2002. 87(3): 292-304. 42. Wang, L., R. Zhao, X. Shi, T. Wei, B.P. Halloran, D.J. Clark, C.R. Jacobs, and W.S. Kingery, Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone, 2009. 45(2): 309-320. 43. Desvergne, B. and W. Wahli, Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Review, 1999. 20(5): 649-688. 44. Ferre, P., The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes, 2004. 53 Suppl 1: S43-50. 45. Barbier, O., I.P. Torra, Y. Duguay, C. Blanquart, J.C. Fruchart, C. Glineur, and B. Staels, Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 2002. 22(5): 717-726. 46. Mourcin, F., N. Grenier, J.F. Mayol, J.J. Lataillade, J.J. Sotto, F. Herodin, and M. Drouet, Mesenchymal stem cells support expansion of in vitro irradiated CD34(+) cells in the presence of SCF, FLT3 ligand, TPO and IL3: potential application to autologous cell therapy in accidentally irradiated victims. Radiation Research, 2005. 164(1): 1-9. 47. Kuo Chieh, P.-Y.T., Chang-Chen Tang, The effect of PPARs on Coronary Heart Disease. Acta Cardiologica Sinica, 2007. 23: 135-142. 48. Ali, F.Y., S.J. Davidson, L.A. Moraes, S.L. Traves, M. Paul-Clark, D. Bishop-Bailey, T.D. Warner, and J.A. Mitchell, Role of nuclear receptor signaling in platelets: antithrombotic effects of PPAR beta. FASEB Journal, 2005. 19(14): 326-340. 49. Law, R.E., S. Goetze, X.-P. Xi, S. Jackson, Y. Kawano, L. Demer, M.C. Fishbein, W.P. Meehan, and W.A. Hsueh, Expression and Function of PPAR{gamma} in Rat and Human Vascular Smooth Muscle Cells. Circulation, 2000. 101(11): 1311-1318. 50. Smith, P.J., Wise, L. S., Berkowitz, R., Wan, C. and Rubin, C. S., Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. Journal of Biological Chemistry, 1998. 263(19): 9402-9408. 51. Lehmann, J.M., J.M. Lenhard, B.B. Oliver, G.M. Ringold, and S.A. Kliewer, Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. Journal of Biological Chemistry, 1997. 272(6): 3406-3410. 52. Barry, F., R.E. Boynton, B.S. Liu, and J.M. Murphy, Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components. Experimental Cell Research, 2001. 268(2): 189-200. 53. Ashton, B.A., T.D. Allen, C.R. Howlett, C.C. Eaglesom, A. Hattori, and M. Owen, Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clinical Orthopaedics and Related Research, 1980(151): 294-307. 54. Johnstone, B., T.M. Hering, A.I. Caplan, V.M. Goldberg, and J.U. Yoo, In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res, 1998. 238(1): 265-272. 55. Chubinskaya, S. and K.E. Kuettner, Regulation of osteogenic proteins by chondrocytes. International Journal of Biochemistry & Cell Biology, 2003. 35(9): 1323-1340. 56. Johnstone, B., T.M. Hering, A.I. Caplan, V.M. Goldberg, and J.U. Yoo, In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Experimental Cell Research, 1998. 238(1): 265-272. 57. Shah, M., D. Foreman, and M. Ferguson, Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. Journal of Cell Science, 1995. 108(3): 985-1002. 58. Ichinose, S., M. Tagami, T. Muneta, and I. Sekiya, Morphological examination during in vitro cartilage formation by human mesenchymal stem cells. Cell and Tissue Research, 2005. 322(2): 217-226. 59. Park, J.S., H.J. Yang, D.G. Woo, H.N. Yang, K. Na, and K.H. Park, Chondrogenic differentiation of mesenchymal stem cells embedded in a scaffold by long-term release of TGF-beta 3 complexed with chondroitin sulfate. Journal of Biomedical Materials Research Part A, 2010. 92A(2): 806-816. 60. Fraser, J.R., T.C. Laurent, and U.B. Laurent, Hyaluronan: its nature, distribution, functions and turnover. Internal Medicine Journal, 1997. 242(1): 27-33. 61. Mikos, A.G., L.V. McIntire, J.M. Anderson, and J.E. Babensee, Host response to tissue engineered devices. Advanced Drug Delivery Reviews, 1998. 33(1-2): 111-139. 62. Kas, H.S., Chitosan: Properties, preparations and application to microparticulate systems. Journal of Microencapsulation, 1997. 14(6): 689-711. 63. Kucera, J., Fungal mycelium--the source of chitosan for chromatography. J Chromatography B Analyst Technological Biomed Life Science, 2004. 808(1): 69-73. 64. Ilium, L., Chitosan and Its Use as a Pharmaceutical Excipient. Pharmaceutical Research, 1998. 15(9): 1326-1331. 65. Amass, W., A. Amass, and B. Tighe, A review of biodegradable polymers: uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies. Polymer International, 1998. 47(2): 89-144. 66. Muzzarelli, R., V. Baldassarre, F. Conti, P. Ferrara, G. Biagini, G. Gazzanelli, and V. Vasi, Biological activity of chitosan: ultrastructural study. Biomaterials, 1988. 9(3): 247-252. 67. Klokkevold, P.R., P. Subar, H. Fukayama, and C.N. Bertolami, Effect of chitosan on lingual hemostasis in rabbits with platelet dysfunction induced by epoprostenol. Journal of Oral and Maxillofacial Surgery, 1992. 50(1): 41-45. 68. Muzzarelli, R.A., C. Zucchini, P. Ilari, A. Pugnaloni, M. Mattioli Belmonte, G. Biagini, and C. Castaldini, Osteoconductive properties of methylpyrrolidinone chitosan in an animal model. Biomaterials, 1993. 14(12): 925-929. 69. Muzzarelli, R.A.A., F. Tanfani, G. Scarpini, and G. Laterza, The degree of acetylation of chitins by gas chromatography and infrared spectroscopy. Journal of Biochemical and Biophysical Methods, 1980. 2(5): 299-306. 70. Klokkevold, P.R., P. Subar, H. Fukayama, and C.N. Bertolami, Effect of chitosan on lingual hemostasis in rabbits with platelet dysfunction induced by epoprostenol. Journal of Oral and Maxillofacial Surgery, 1992. 50(1): 41-45. 71. Vilanova, E., J. Barril, and V. Carrera, Biochemical properties and possible toxicological significance of various forms of NTE. Chemico-Biological Interactions, 1993. 87(1-3): 369-381. 72. Fakhry, A., G.B. Schneider, R. Zaharias, and S. Senel, Chitosan supports the initial attachment and spreading of osteoblasts preferentially over fibroblasts. Biomaterials, 2004. 25(11): 2075-2079. 73. Lim, T.Y., W. Wang, Z.L. Shi, C.K. Poh, and K.G. Neoh, Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2. Journal of Materials Science-Materials in Medicine, 2009. 20(1): 1-10. 74. Moreau, J.L. and H.H.K. Xu, Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate - Chitosan composite scaffold. Biomaterials, 2009. 30(14): 2675-2682. 75. Sechriest, V.F., Y.J. Miao, C. Niyibizi, A. Westerhausen-Larson, H.W. Matthew, C.H. Evans, F.H. Fu, and J.K. Suh, GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesis. Journal of Biomedical Materials Research, 2000. 49(4): 534-541. 76. (EDT), B.A., Molecular biology of the cell. 4th edition. Garland Science Press, New York, 2002: Chapter 19. 77. Zaia, J., J.E. McClellan, and C.E. Costello, Tandem mass spectrometric determination of the 4S/6S sulfation sequence in chondroitin sulfate oligosaccharides. Analytical Chemistry, 2001. 73(24): 6030-6039. 78. Denuziere, A., D. Ferrier, O. Damour, and A. Domard, Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties. Biomaterials, 1998. 19(14): 1275-1285. 79. NADANAKA S(Nippi Res. Inst. Biomatrix, T., Jpn), Chondroitin Sulfate: Structure, Function, and Biosynthesis. Trends Glycoscience Glycotechnology. 11(60): 233-238. 80. Varghese, S., N.S. Hwang, A.C. Canver, P. Theprungsirikul, D.W. Lin, and J. Elisseeff, Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. Matrix Biology, 2008. 27(1): 12-21. 81. Freichel, O.L. and B.C. Lippold, A new oral erosion controlled drug delivery system with a late burst in the release profile. European Journal of Pharmaceutics and Biopharmaceutics, 2000. 50(3): 345-351. 82. Smith, Q.R., Transport of glutamate and other amino acids at the blood-brain barrier. Journal of Nutrition, 2000. 130(4S Suppl): 1016S-1022S. 83. LaMantia, A.-S., The usual suspects: GABA and glutamate may regulate proliferation in the neocortex. Neuron, 1995. 15(6): 1223-1225. 84. Gallo, V., J. Zhou, C. McBain, P. Wright, P. Knutson, and R. Armstrong, Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. Journal of Neuroscience, 1996. 16(8): 2659-2670. 85. Iemata, M., T. Takarada, E. Hinoi, H. Taniura, and Y. Yoneda, Suppression by glutamate of proliferative activity through glutathione depletion mediated by the Cystine/Glutamate antiporter in mesenchymal C3H10T1/2 stem cells. Journal of Cellular Physiology, 2007. 213: 721-729. 86. Lin, W.C., D.G. Yu, and M.C. Yang, Blood compatibility of novel poly(gamma-glutamic acid)/polyvinyl alcohol hydrogels. Colloids Surf B Biointerfaces, 2006. 47(1): 43-49. 87. Hsieh, C.-Y., S.-P. Tsai, D.-M. Wang, Y.-N. Chang, and H.-J. Hsieh, Preparation of [gamma]-PGA/chitosan composite tissue engineering matrices. Biomaterials, 2005. 26(28): 5617-5623. 88. Uygun, B.E., S.E. Stojsih, and H.W.T. Matthew, Effects of Immobilized Glycosaminoglycans on the Proliferation and Differentiation of Mesenchymal Stem Cells. Tissue Engineering Part A, 2009. 15(11): 3499-3512. 89. Shi, Z., K.G. Neoh, E.T. Kang, C.K. Poh, and W. Wang, Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules, 2009. 10(6): 1603-1611. 90. 范宏斌, 胡蘊玉, 李旭升, 吕榮, 白建萍, and 王軍, 明膠-硫酸軟骨素-透明質酸鈉作為組織工程軟骨支架的實驗研究. 中國修復重建外科雜誌, 2005. 19(6): 473-477. 91. Wu, Y.N., Z. Yang, J.H.P. Hui, H.W. Ouyang, and E.H. Lee, Cartilaginous ECM component-modification of the micro-bead culture system for chondrogenic differentiation of mesenchymal stem cells. Biomaterials, 2007. 28(28): 4056-4067. 92. S. Facca, C.C., C. Mendoza-Palomares, N. Messadeq, A. Dierich, A. P. R. Johnston, D. Mainard, J.-C. Voegel, F. Caruso, and N. Benkirane-Jessel, Active multilayered capsules for in vivo bone formation. Proceedings of the National Academy of Sciences, 2009. 107(8): 3406-3411. 93. 苑乃義, 幾丁聚醣、硫酸軟骨素與麩胺酸複合生醫基材之製程探討、性質改良與應用. 國立台灣大學工學院化學工程學研究所博士論文, 2009. 94. Karen, P., T. Rosalba, and J. Daisy, Sensitivity of a novel biotin-free detection reagent (powervision+) for immunohistochemistry. Journal of histotechnology, 2002. 25: 247-250 95. Rotman, B. and B.W. Papermaster, Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proceedings of the National Academy of Sciences, 1966. 55(1): 134-141. 96. Prudencio, C., B. Abrantes, I. Lopes, and M.A. Tavares, Structural and functional cellular alterations underlying the toxicity of methamphetamine in rat retina and prefrontal cortex. Annals of the New York Academy of Sciences, 2002. 965: 522-528. 97. Bernardi, P., L. Scorrano, R. Colonna, V. Petronilli, and F. Di Lisa, Mitochondria and cell death. Mechanistic aspects and methodological issues. European Journal of Biochemistry, 1999. 264(3): 687-701. 98. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 1976. 72: 248-254. 99. Mcgee-Russell, S.M., Histochemical methods for cacium. Journal of Histochemistry and Cytochemistry, 1958. 6(1): 22-42. 100. Ho, Y.-C., Y.-C. Chung, S.-M. Hwang, K.-C. Wang, and Y.-C. Hu, Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. The Journal of Gene Medicine, 2005. 7(7): 860-868. 101. Simmons, D., A. Satterthwaite, D. Tenen, and B. Seed, Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol, 1992. 148(1): 267-271. 102. Satterthwaite, A.B., T.C. Burn, M.M. Le Beau, and D.G. Tenen, Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics, 1992. 12(4): 788-794. 103. Furness, S. and K. McNagny, Beyond mere markers. Immunologic Research, 2006. 34(1): 13-32. 104. Sackstein, R., J.S. Merzaban, D.W. Cain, N.M. Dagia, J.A. Spencer, C.P. Lin, and R. Wohlgemuth, Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med, 2008. 14(2): 181-187. 105. Napier, S.L., Z.R. Healy, R.L. Schnaar, and K. Konstantopoulos, Selectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells. Journal of Biological Chemistry, 2007. 282(6): 3433-3441. 106. Elshal, M.F., S.S. Khan, Y. Takahashi, M.A. Solomon, and J.P. McCoy, Jr, CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood, 2005. 106(8): 2923-2924. 107. Caplan, A.I., Mesenchymal stem cells. Journal of Orthopaedic Research., 1991. 9(5): 641-650. 108. Abeyta, M.J., A.T. Clark, R.T. Rodriguez, M.S. Bodnar, R.A.R. Pera, and M.T. Firpo, Unique gene expression signatures of independently-derived human embryonic stem cell lines. Human Molecular Genetics, 2004. 13(6): 601-608. 109. Looijenga, L.H.J., H. Stoop, H.P.J.C. de Leeuw, C.A. de Gouveia Brazao, A.J.M. Gillis, K.E.P. van Roozendaal, E.J.J. van Zoelen, R.F.A. Weber, K.P. Wolffenbuttel, H. van Dekken, F. Honecker, C. Bokemeyer, E.J. Perlman, D.T. Schneider, J. Kononen, G. Sauter, and J.W. Oosterhuis, POU5F1 (OCT3/4) Identifies Cells with Pluripotent Potential in Human Germ Cell Tumors. Cancer Research, 2003. 63(9): 2244-2250. 110. Rodda, D.J., J.-L. Chew, L.-H. Lim, Y.-H. Loh, B. Wang, H.-H. Ng, and P. Robson, Transcriptional Regulation of Nanog by OCT4 and SOX2. Journal of Biological Chemistry, 2005. 280(26): 24731-24737. 111. Hyslop, L., M. Stojkovic, L. Armstrong, T. Walter, P. Stojkovic, S. Przyborski, M. Herbert, A. Murdoch, T. Strachan, and M. Lako, Downregulation of NANOG Induces Differentiation of Human Embryonic Stem Cells to Extraembryonic Lineages. Stem Cells, 2005. 23(8): 1035-1043. 112. Jong-Hyun Oh, H.-J.D., Heung-Mo Yang, Shin-Yong Moon, Kwang-Yul Cha, Hyung-Min Chung and Jae-Hwan Kim, Identification of a putative transactivation domain in human Nanog. Experimental and Mollecular Medicine, 2005. 37(3): 250-254. 113. Jung Sun Kim, J.K., Byung Soo Kim, Hee Yong Chung, Young Yiul Lee, Choon-Sik Park, Young Seek Lee, Young Han Lee and Il Yup Chung, Identification and functional characterization of an alternative splice variant within the fourth exon of human nanog. Experimental and Molecular Medicine, 2005. 37(6): 601-607. 114. Christenson, R.H., Biochemical markers of bone metabolism: an overview. Clinical Biochemistry, 1997. 30(8): 573-593. 115. Camozzi, V., A. Tossi, E. Simoni, F. Pagani, C.M. Francucci, and L. Moro, Role of biochemical markers of bone remodeling in clinical practice. Journal of Endocrinological Investigation, 2007. 30(6 Suppl): 13-17. 116. Kim, S.Y., S.M. Park, and S.-T. Lee, Apolipoprotein C-II is a novel substrate for matrix metalloproteinases. Biochemical and Biophysical Research Communications, 2006. 339(1): 47-54. 117. Okubo, M., A. Horinishi, M. Saito, T. Ebara, Y. Endo, K. Kaku, T. Murase, and M. Eto, A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency. Molecular Genetics and Metabolism, 2007. 92(3): 229-233. 118. Jones, J.R., C. Barrick, K.-A. Kim, J. Lindner, B. Blondeau, Y. Fujimoto, M. Shiota, R.A. Kesterson, B.B. Kahn, and M.A. Magnuson, Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America, 2005. 102(17): 6207-6212. 119. Doege, K.J., M. Sasaki, T. Kimura, and Y. Yamada, Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. Journal of Biological Chemistry, 1991. 266(2): 894-902. 120. East, C.J., H. Stanton, S.B. Golub, F.M. Rogerson, and A.J. Fosang, ADAMTS-5 Deficiency Does Not Block Aggrecanolysis at Preferred Cleavage Sites in the Chondroitin Sulfate-rich Region of Aggrecan. Journal of Biological Chemistry, 2007. 282(12): 8632-8640. 121. Swalla, B.J., W.B. Upholt, and M. Solursh, Analysis of type II collagen RNA localization in chick wing buds by in situ hybridization. Developmental Biology, 1988. 125(1): 51-58. 122. Ng, L.J., S. Wheatley, G.E. Muscat, J. Conway-Campbell, J. Bowles, E. Wright, D.M. Bell, P.P. Tam, K.S. Cheah, and P. Koopman, SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Developmental Biology, 1997. 183(1): 108-121. 123. Bernfield, M., M. Gotte, P.W. Park, O. Reizes, M.L. Fitzgerald, J. Lincecum, and M. Zako, Functions of cell surface heparan sulfate proteoglycans. Annual Review of Biochemistry, 1999. 68: 729-777. 124. Nandini, C.D. and K. Sugahara, Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors. Advances In Pharmacology, 2006. 53: 253-279. 125. Rapraeger, A.C., A. Krufka, and B.B. Olwin, Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science, 1991. 252(5013): 1705-1708. 126. Yayon, A., M. Klagsbrun, J.D. Esko, P. Leder, and D.M. Ornitz, Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 1991. 64(4): 841-848. 127. Jackson, R.A., S. Murali, A.J. van Wijnen, G.S. Stein, V. Nurcombe, and S.M. Cool, Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J Cell Physiol, 2007. 210(1): 38-50. 128. Deepa, S.S., Y. Umehara, S. Higashiyama, N. Itoh, and K. Sugahara, Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues. The Journal of Biological Chemistry, 2002. 277(46): 43707-43716. 129. Campbell, E.J. and C.A. Owen, The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. The Journal of Biological Chemistry, 2007. 282(19): 14645-14654. 130. Russo, V.C., L.A. Bach, A.J. Fosang, N.L. Baker, and G.A. Werther, Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology, 1997. 138(11): 4858-4867. 131. Byers, R.J., J. Brown, C. Brandwood, P. Wood, W. Staley, L. Hainey, A.J. Freemont, and J.A. Hoyland, Osteoblastic differentiation and mRNA analysis of STRO-1-positive human bone marrow stromal cells using primary in vitro culture and poly (A) PCR. The Journal of Pathology, 1999. 187(3): 374-381. 132. Stewart, K., S. Walsh, J. Screen, C.M. Jefferiss, J. Chainey, G.R. Jordan, and J.N. Beresford, Further Characterization of Cells Expressing STRO-1 in Cultures of Adult Human Bone Marrow Stromal Cells. Journal of Bone and Mineral Research, 1999. 14(8): 1345-1356. 133. Ahdjoudj, S., F. Lasmoles, B.O. Oyajobi, A. Lomri, P. Delannoy, and P.J. Marie, Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. Journal of Cellular Biochemistry, 2001. 81(1): 23-38. 134. Bianco, P., M. Riminucci, S. Gronthos, and P.G. Robey, Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001. 19(3): 180-192. 135. Kumarasuriyar, A., S. Murali, V. Nurcombe, and S.M. Cool, Glycosaminoglycan composition changes with MG-63 osteosarcoma osteogenesis in vitro and induces human mesenchymal stem cell aggregation. Journal of Cellular Physiology, 2009. 218(3): 501-511. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47325 | - |
dc.description.abstract | 適當的幹細胞增殖分化技術及良好的生醫材料在組織工程應用上極為重要。本研究以細胞分化為目標,針對不同生醫材料的效應進行深入研究及探討。本研究使用幾丁聚醣作為主要之生醫材料,並添加硫酸軟骨素及麩胺酸形成各種複合材料以之進行間葉幹細胞之體外培養,並由光學顯微鏡觀察細胞型態以及細胞DNA的定量來探討生醫材料對間葉幹細胞增殖之影響。其次利用即時定量聚合酶反應 (real-time polymerase chain reaction, real-time PCR ) 觀察在不同分化培養基刺激下各基因表現量。Oct-4及Nanog表現量明顯下降,可看出間葉幹細胞已改變其細胞狀態而朝向特定方向分化。針對骨分化成效觀察細胞之骨鈣素 (osteocalcin, OCN) 基因表現並以Alizarin red S染色觀察鈣分泌;脂肪分化成效觀察過氧化體增殖活化受體 (peroxisome proliferator-activator receptor-γ2, PPAR-γ2) 與脂蛋白酯酶 (lipoprotein lipase, LPL) 基因表現,並以Oil red O染色觀察油滴分布;軟骨分化成效則觀察aggrecan和第二型膠原蛋白 (type II collagen, Col2) 基因表現量及以Toluidine blue及Safranin O染色觀察醣胺素分佈,結果各生醫材料均對分化有較佳效果。
由實驗結果整體來看,幾丁聚醣材料在加入硫酸軟骨素及麩胺酸雖然無法增加間葉幹細胞之貼附與增殖能力,但在分化實驗中卻較控制組 (TCPS材料) 組有更為優越的效果,在細胞型態上也形成與生理上類似的細胞團塊。在骨分化成效上以幾丁聚醣為佳,在脂肪與軟骨分化成效上則以96/4/8 (幾丁聚醣/硫酸軟骨素/麩胺酸複合材料)為佳,將來在骨骼及軟骨組織工程上,十分具有應用潛力。 | zh_TW |
dc.description.abstract | Suitable stem cell sources with good expansion and differentiation technique, as well as excellent biomaterials are important for tissue engineering applications. In this study, we aimed at the development of new biomaterials for the in vitro expansion and differentiation of bone marrow mesenchymal stem cell (BMSCs). Chondroitin sulfate and glutamic acid were used to modify chitosan in order to prepare composite biomaterials. Inverted microscopy and cellular DNA quantification were used to detect the influence of the biomaterials on the proliferation of BMSCs. Real-time PCR was also used to detect the gene expressions in BMSCs. The gene expressions of Oct-4 and Nanog in BMSCs were lower when they were exposed to a certain differentiation stimuli, thus revealing that cells morphology changed and specific differentiation started. We examine the gene expression of osteocalcin (OCN) and use Alizarin red S staining to detect calcium deposit after BMSCs exposed to osteogenic stimulus (OS), the gene expressions of peroxisome proliferator-activator receptor-γ2 (PPAR-γ2), lipoprotein lipase (LPL) and use of Oil red O staining to detect oil secretion when BMSC were exposed to adipogenic stimulus (AS), the gene expression of aggrecan and type II collagen and use of Toluidine blue and Safranin O staining to detect glycosaminoglycan (GAG) when BMSCs were exposed to chondrogenic stimulus (CS) respectively.
In summary, although the addition of chondroitin sulfate and glutamic acid to biomaterial did not improve the attachment and proliferation of BMSCs, the chitosan-based composite biomaterials developed in this study had superior effect than tissue culture polystyrene (TCPS) material in cell differentiation. The chitosan biomaterial was suitable for osteogeic differentiation, while chitosan/chondroitin sulfate/glutamic acid composite biomaterial was suitable for adipogenic and chondrogenic differentiation. Therefore, these biomaterials can be good candidates for bone- and cartilage-repairing tissue engineering applications. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T05:55:05Z (GMT). No. of bitstreams: 1 ntu-99-R97524017-1.pdf: 4085227 bytes, checksum: 53d356df73db72876740c5a0f1b3761f (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 誌謝 i
中文摘要 iii Abstract v 目錄 vii 圖目錄 xi 表目錄 xv 縮寫與符號說明 xvii 中英名詞對照 xix 1 緒論 1 1.1 研究背景與動機 1 1.2 研究組織架構 2 2 文獻回顧 5 2.1 組織工程 5 2.2 幹細胞 6 2.3 間葉幹細胞 10 2.3.1 間葉幹細胞之增殖及其基因表現 10 2.3.2 間葉幹細胞之骨分化及其基因表現 16 2.3.3 間葉幹細胞之脂肪分化及其基因表現 17 2.3.4 間葉幹細胞之軟骨分化及其基因表現 20 2.3.5 生醫材料 24 2.3.6 幾丁聚醣 24 2.3.7 硫酸軟骨素 26 2.3.8 麩胺酸 27 2.3.9 幹細胞培養於幾丁聚醣、硫酸軟骨素及麩胺酸之相關研究 28 3 實驗藥品與方法 31 3.1 實驗材料 31 3.1.1 生醫材料 31 3.1.2 細胞培養所需材料 31 3.1.3 細胞培養一般耗材 32 3.1.4 免疫染色試劑 33 3.1.5 FDA / PI 雙螢光染色法 33 3.1.6 抽取細胞之DNA之試劑 34 3.1.7 抽取細胞之RNA之試劑 34 3.1.8 細胞之總蛋白質定量試劑 34 3.1.9 反轉錄聚合酶連鎖反應所用之材料 34 3.1.10 鈣染色試劑 (Alizarin red S staining) 36 3.1.11 油滴染色試劑 (Oil red O staining) 36 3.1.12 醣胺素染色試劑 (Toluidine blue and Safranin O) 36 3.2 實驗儀器 37 3.3 實驗原理與方法 38 3.3.1 細胞培養基材之製備 38 3.3.2 所使用細胞株及培養條件 38 3.3.3 細胞繼代培養於十二孔盤 39 3.3.4 骨母細胞誘導分化培養液之配製 39 3.3.5 脂肪細胞誘導分化培養液之配製 40 3.3.6 軟骨細胞誘導分化培養液之配製 40 3.3.7 免疫染色 40 3.3.8 FDA / PI 雙螢光染色法 41 3.3.9 細胞總DNA之抽取 42 3.3.10 細胞總蛋白質含量測定 42 3.3.11 細胞總RNA的抽取 42 3.3.12 細胞特定基因表現量:two step RT-PCR 43 3.4 骨母細胞誘導分化 (Osteoblast differentiation) 45 3.4.1 鈣沉澱染色 (Alizarin red S staining) 45 3.5 脂肪細胞誘導分化 (Adipocyte differentiation) 45 3.5.1 油滴染色 (Oil red O staining) 46 3.6 軟骨細胞誘導分化 (Chondrocyte differentiation) 46 3.6.1 醣胺素染色 (Toluidine blue and Safranin O) 46 4 結果與討論 47 4.1 間葉幹細胞增殖能力探討 47 4.1.1 各種生醫材料表面之細胞培養 47 4.1.2 FDA / PI 雙螢光染色 50 4.1.3 DNA及Protein 定量 52 4.1.4 免疫染色 55 4.1.5 Real-time PCR 測定Oct-4及Nanog表現量 57 4.2 間葉幹細胞之骨分化效應 60 4.2.1 Real-time PCR 測定OCN表現量 60 4.2.2 Alizarin red S 染色結果 62 4.3 間葉幹細胞之脂肪分化效應 65 4.3.1 Real-time PCR 測定LPL及PPAR-γ2表現量 65 4.3.2 油滴染色結果 (Oil red O staining) 69 4.4 間葉幹細胞之軟骨分化效應 72 4.4.1 Real-time PCR 測定aggrecan及type II collagen表現量 72 4.4.2 醣胺素染色結果 76 4.5 綜合討論 82 5 結論及未來研究方向 85 5.1 結論 85 5.2 未來研究方向 86 6 參考文獻 89 | |
dc.language.iso | zh-TW | |
dc.title | 幾丁聚醣/硫酸軟骨素/麩胺酸複合材料對於骨髓間葉幹細胞分化潛能之效應 | zh_TW |
dc.title | Effects of Chitosan/Chondroitin Sulfate/Glutamic Acid Composite Materials on the Differentiation of Bone Marrow Mesenchymal Stem Cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 洪士杰,何明樺 | |
dc.subject.keyword | 幾丁聚醣,硫酸軟骨素,麩胺酸,骨髓間葉幹細胞株,骨分化,脂肪分化,軟骨分化, | zh_TW |
dc.subject.keyword | chitosan,chondroitin sulfate,glutamic acid,bone marrow mesenchymal stem cell,osteogenesis,adipogenesis,chondrogenesis, | en |
dc.relation.page | 97 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-08-18 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 化學工程學研究所 | zh_TW |
顯示於系所單位: | 化學工程學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-99-1.pdf 目前未授權公開取用 | 3.99 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。